Your session is about to expire
← Back to Search
Tobacco Cessation Treatment for Peripheral Arterial Disease (PAD Trial)
PAD Trial Summary
This trial is testing whether integrating tobacco cessation services into a dedicated peripheral artery disease clinic can improve quitting rates and health outcomes in PAD patients.
PAD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPAD Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PAD Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Am I eligible to partake in this experiment?
"With peripheral arterial disease, 40 individuals aged 18 to 100 are being enrolled in this trial. To qualify for participation certain factors must be met: a medical diagnosis of PAD, the ability to understand English and commit to all scheduled appointments, as well as being an active tobacco user."
Does the current study require more participants?
"As per the clinicaltrials.gov website, this experiment is currently not taking in participants. This research project was initially posted on August 16th 2022 and recently updated October 3rd of that same year. Despite being inactive for recruitment at present, there are 226 other trials actively seeking volunteers now."
Is this specific research open to participants aged 65 and up?
"The lower age limit for inclusion in this medical trial is 18, while the upper threshold to be eligible stands at 100 years old."
Share this study with friends
Copy Link
Messenger